As previously discussed in my articles, "Breast Implants Linked to Rare Lymphoma Blood Cancer" and "Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable, the FDA recently updated their 2011 report of the association between breast implants and anaplastic large-cell lymphoma (ALCL), providing additional information on this rare form of … [Read more...]
Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable
As news of the possible link between breast implants and a rare form of lymphoma cancer has spread, more theories about how it develops have come to light. One such theory is outlined in the excerpt, below, from the article, "Increase in Australian cancer cases linked to breast implants": Dr. Gazi Hussain, Vice President of the Australian … [Read more...]
Breast Implants Lymphoma Cancer: Diagnosis And Treatment Developments
The medical literature about breast implant-associated ALCL (BIA-ALCL) grew considerably in 2015, and reflected a better understanding of the diagnosis and treatment aspects of this rare form of lymphoma. In February 2015 this article, "Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert … [Read more...]
March 2017 FDA Report: Breast Implants Linked To Lymphoma Blood Cancer
You may have heard about the March 2017 FDA update report concerning a little-known and rare type of lymphoma, or blood cancer, which has been developing in some women who have had breast implant procedures done for augmentation or reconstruction purposes. From this March 21, 2017 article, "9 Deaths Are Linked to Rare Cancer From Breast … [Read more...]
Breast Implants Linked to Rare Lymphoma Blood Cancer
The FDA first identified a possible link between breast implants and anaplastic large cell lymphoma (ALCL) in their report from January 2011. ALCL is a rare type of blood cancer that is classified as a non-Hodgkin lymphoma, and one of the subtypes of T-cell lymphoma. It can initially appear either in the skin, in the lymph nodes, or in organs … [Read more...]